STRYKER CORP Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31)
STRYKER CORP (SYK) had Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) of $69.00 million as of 2013-06-30, per its 10-Q filed 2013-07-23.
Discontinued › Notes › Business Combinations
us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue · last filed 2013-07-23
- 2013-06-30: Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) $69.00M.
- 2013-03-31: Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) $98.00M.
- 2012-12-31: Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) $103.00M.
- 2012-09-30: Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) $73.00M.
| Period end | Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) | Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) as first filed |
|---|---|---|
| 2013-06-30 | $69.00M 10-Q · filed 2013-07-23 | |
| 2013-03-31 | $98.00M 10-Q · filed 2013-04-30 | |
| 2012-12-31 | $103.00M 10-Q · filed 2013-07-23 | |
| 2012-09-30 | $73.00M 10-Q · filed 2012-10-22 | |
| 2012-06-30 | $88.00M 10-Q · filed 2012-07-24 | |
| 2012-03-31 | $85.00M 10-Q · filed 2012-04-24 | |
| 2011-12-31 | $115.00M 10-K · filed 2013-02-27 | $85.00M 10-Q · filed 2012-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |